Lidocaine Impurity 7 | CAS 70336-49-1 - Request Quote
Lidocaine Impurity 7
| SZ CAT No: | SZ-L023032 |
| CAS No | 70336-49-1 |
| Mol.F. | C20H22N2O2 |
| Mol.Wt. | 322.4 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lidocaine Impurity 7 is chemically 1,4-Bis(2,6-dimethylphenyl)piperazine-2,5-dione. Lidocaine Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Lidocaine Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lidocaine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 70336-49-1
Purchase 70336-49-1
Order 70336-49-1
Enquire 70336-49-1
price of 70336-49-1
70336-49-1 Supplier
70336-49-1 Manufacturer
70336-49-1 Exporter
buy high quality Lidocaine Impurity 7
Purchase Lidocaine Impurity 7
Lidocaine Impurity 7 suppliers
Lidocaine Impurity 7 manufacturers
Lidocaine Impurity 7 price
Order Lidocaine Impurity 7
Enquire Lidocaine Impurity 7
Lidocaine Impurity 7 cost
Lidocaine Impurity 7 Supplier
Lidocaine Impurity 7 Distributor
Lidocaine Impurity 7 for Method Validation
Lidocaine Reference Standard
Lidocaine Impurity 7 for ANDA Filing
Lidocaine Impurity 7 for Forced Degradation Studies
Lidocaine Impurity 7 Identification Standards
Lidocaine Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


